Combined modality trials in early breast cancer have been underway since the 1960s and results are available to indicate varying degrees of success in Stage I and 11. The trials have involved more than 29,000 women in 61 randomized trials. The recommendations can be summarized by stage, estrogen rec
Therapy of breast cancer
โ Scribed by H. Tagnon; M. Schwaiger; H. J. Peiper; A. P. M. Forrest; B. Fisher; R. Amalric; Ch. Herfarth
- Publisher
- Springer
- Year
- 1978
- Tongue
- English
- Weight
- 929 KB
- Volume
- 346
- Category
- Article
- ISSN
- 1435-2451
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
About 180,000 American women will be diagnosed with early stage breast cancer during 1993. In many of these patients breast cancer is a systemic disease at diagnosis and thus not curable by local treatment alone. The development of optimal forms of systemic adjuvant therapy has been a major area of
Systematic adjuvant therapy has improved the outcome for women with operable breast cancer. As a result, a substantial proportion of patients with this disease are candidates for adjuvant treatment. In providing a woman with recommendations for therapy, her risk of developing recurrent breast cancer